Cell Signaling Technology

GABA(B)R1 Antibody

#3835 · $317

100
Citing papers
12.9k
Combined citations
Supplier page Find this product

Research areas

Immune Response and Inflammation8Cancer, Hypoxia, and Metabolism7RNA modifications and cancer6Cancer Cells and Metastasis6Autophagy in Disease and Therapy6Metabolism, Diabetes, and Cancer6Immune cells in cancer6Cell death mechanisms and regulation5

Papers citing this product

1
Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3
American Journal Of Pathology·2004·536 cit.·DOI
2
Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation
Journal of Clinical Investigation·2005·314 cit.·DOI
3
PD-L1 expression in colorectal cancer is associated with microsatellite instability, BRAF mutation, medullary morphology and cytotoxic tumor-infiltrating lymphocytes
Modern Pathology·2016·306 cit.·DOI
4
Regulatory B Cells Limit CNS Inflammation and Neurologic Deficits in Murine Experimental Stroke
Journal of Neuroscience·2011·294 cit.·DOI
5
Transforming Growth Factor Beta Signaling in Hepatocytes Participates in Steatohepatitis Through Regulation of Cell Death and Lipid Metabolism in Mice
Hepatology·2013·272 cit.·DOI
6
A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia
Experimental Hematology·2006·258 cit.·DOI
7
AMP-activated Protein Kinase Is Activated as a Consequence of Lipolysis in the Adipocyte
Journal of Biological Chemistry·2008·244 cit.·DOI
8
Ryanodine Receptor Blockade Reduces Amyloid-β Load and Memory Impairments in Tg2576 Mouse Model of Alzheimer Disease
Journal of Neuroscience·2012·234 cit.·DOI
9
AMP-activated protein kinase and ATP-citrate lyase are two distinct molecular targets for ETC-1002, a novel small molecule regulator of lipid and carbohydrate metabolism
Journal of Lipid Research·2012·234 cit.·DOI
10
Tissue- and cell-type–specific manifestations of heteroplasmic mtDNA 3243A>G mutation in human induced pluripotent stem cell-derived disease model
Proceedings of the National Academy of Sciences·2013·204 cit.·DOI